Title

Management of Cryptococcal Disease

Authoring Organization

Infectious Diseases Society of America

Publication Month/Year

February 1, 2010

Last Updated Month/Year

November 25, 2024

Supplemental Implementation Tools

Document Type

Guideline

External Publication Status

Published

Country of Publication

US

Target Patient Population

Patients with human immunodeficiency virus (HIV)–infection, organ transplant recipients, and non–HIV infected and nontransplant hosts

PICO Questions

  1. WHAT ARE THE MOST APPROPRIATE TREATMENT STRATEGIES IN THE PATIENT WITH CRYPTOCOCCAL MENINGOENCEPHALITIS?

  2. HOW ARE COMPLICATIONS MANAGED IN PATIENTS WITH CRYPTOCOCCOSIS?

  3. WHAT ARE THE APPROPRIATE TREATMENT STRATEGIES FOR PATIENTS WITH NONMENINGEAL CRYPTOCOCCOSIS?

  4. WHAT IS THE APPROPRIATE TREATMENT FOR CRYPTOCOCCOSIS IN SPECIAL CLINICAL SITUATIONS (PREGNANT WOMEN, CHILDREN, RESOURCE-LIMITED ENVIRONMENT, AND C. GATTII INFECTION)?

Inclusion Criteria

Male, Female, Adolescent, Adult, Child, Older adult

Health Care Settings

Ambulatory, Hospital

Intended Users

Nurse, nurse practitioner, physician, physician assistant

Scope

Treatment, Management

Diseases/Conditions (MeSH)

D003454 - Cryptococcus

Keywords

fungal infection, cryptococcosis, cryptococcoma, cryptococcus, Cryptococcus neoformans, C. neoformans

Source Citation

Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, Harrison TS, Larsen RA, Lortholary O, Nguyen MH, Pappas PG, Powderly WG, Singh N, Sobel JD, Sorrell TC. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2010 Feb 1;50(3):291-322.